Noninvasive method to quantify kidney function and functional decline
View Patent ↗Disclose are methods, compositions and kits for the determination of kidney function that provide an alternative to the standard-of-cure used for eGFR calculations. Described herein are methods for quantitative measurement of ADMA and hydration markers in a urine sample, and process used to transform the input of these methods into a measure of kidney function. The methods allow ADMA and other biomarkers to be detected in urine samples from a subject using a simple and inexpensive assay that can be easily performed noninvasively and only require urine samples for the prediction of kidney function.
1. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample and the hydration status of the subject; and
determining the kidney function of the subject based on the value,
wherein generating a value indicative of the kidney function of the subject comprises inputting the amount of ADMA, the hydration status, and the age or gender of the subject into an algorithm to produce the value.
2. The method of claim 1 , wherein the algorithm is implemented via a computer system.
3. The method of claim 2 , wherein determining the kidney function of the subject comprises comparing the value to a threshold and determining the kidney function of the subject based on the comparison.
4. The method of claim 3 , wherein generating the value indicative of the kidney function of the subject comprises inputting a determined amount of a hydration marker from the urine sample into the algorithm to produce the value.
5. The method of claim 4 , wherein the hydration marker is creatinine.
6. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample and the hydration status of the subject; and
determining the kidney function of the subject based on the value, wherein generating the value indicative of the kidney function of the subject comprises further inputting an amount of total protein from the sample into the algorithm.
7. The method of claim 1 , wherein a race of the subject is not input into the algorithm.
8. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample and the hydration status of the subject; and
determining the kidney function of the subject based on the value, wherein the amount of urine ADMA from the urine sample of the subject positively correlates with glomerular filtration rate (GFR) estimated from plasma.
9. The method of claim 1 , wherein the value indicative of the kidney function of the subject is an estimated GFR.
10. The method of claim 1 , wherein the hydration status of the subject is an amount of a urinary marker that is indicative of a hydration level in the subject.
11. The method of claim 10 , wherein the urinary marker that is indicative of a hydration level in the subject is urine creatinine.
12. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample, wherein the reagent is selected from N-hydrosuccinimido carbonic acid; (2,5-dioxopyrrolidin-1yl)hydrogen carbonate (also known as succinimidocarbonate); N,N′-disuccinimidyl carbonate; carbonic acid (choloromethyl ester) (N-hydroxysuccinimide ester); or (2,5-dioxopyrrolidin-1-yl)prop-2-enyl carbonate;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample and the hydration status of the subject; and
determining the kidney function of the subject based on the value.
13. The method of claim 12 , wherein the step of detecting the amount of ADMA from the urine sample of the subject comprises:
contacting the urine sample with an antibody immobilized on the wall of a microtiter well that specifically binds to ADMA in the urine sample; and
detecting an amount of the antibody on the wall of a microtiter well that is in a bound state.
14. The method of claim 13 , wherein the antibody that specifically binds ADMA has a reactivity for symmetric dimethylarginine (SDMA) that is less than 25%, less than 10%, less than 5%, or less than 1% of its reactivity for ADMA.
15. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample and the hydration status of the subject; and
determining the kidney function of the subject based on the value, wherein the subject is identified as having impaired kidney function when the ADMA is in the urine sample at a concentration of less than 19.4 μM.
16. A method for determining kidney function of a subject from a urine sample, the method comprising:
detecting an amount of asymmetric dimethylarginine (ADMA) from a urine sample of a subject by coupling a reagent to the ADMA prior to detecting the amount of ADMA from the urine sample;
assaying the urine sample to determine a hydration status of the subject;
generating a value indicative of the kidney function of the subject based on the amount of the reagent coupled to the ADMA from the urine sample, the hydration status of the subject; and
determining the kidney function of the subject based on the value, wherein the subject is identified as having impaired kidney function when the ADMA/creatinine ratio is less than 0.7 μM/mg/dL.
17. The method of claim 1 , further comprising (1) identifying the subject as having impaired kidney function and (2) administering a treatment to the subject based on the identified impairment of kidney function.
18. The method of claim 8 , wherein the algorithm is implemented via a computer system.
19. The method of claim 8 , wherein determining the kidney function of the subject comprises comparing the value to a threshold and determining the kidney function of the subject based on the comparison.
20. The method of claim 8 , wherein generating the value indicative of the kidney function of the subject comprises inputting a determined amount of a hydration marker from the urine sample into the algorithm to produce the value.
21. The method of claim 8 , wherein the hydration marker is creatinine.
22. The method of claim 8 , wherein a race of the subject is not input into the algorithm.
23. The method of claim 8 , wherein the value indicative of the kidney function of the subject is an estimated GFR.
24. The method of claim 8 , wherein the hydration status of the subject is an amount of a urinary marker that is indicative of a hydration level in the subject.
25. The method of claim 8 , wherein the urinary marker that is indicative of a hydration level in the subject is urine creatinine.